We recently launched our artificial intelligence (AI) driven Endocrine Briefing e-newsletter for members. Below are answers to some frequently asked questions about this exciting new publication.
Frequently Asked Questions About Rasa.io E-Newsletter
+ Why did the Society change to a new e-newsletter format?
-
Our new e-newsletter uses industry-leading artificial intelligence technology to bring you endocrine research and practice headlines personalized for you. As you click on links to stories that interest you, the platform uses that data to select related content for future issues personalized for you. We chose this platform to provide a customized e-newsletter experience for our more than 18,000 members and their diverse interests.
+ When can I expect to receive my new Endocrine Briefing e-newsletter?
-
Endocrine Briefing is delivered each Monday at 2 PM Eastern. The subject line will begin with “Endocrine Briefing” so you can easily spot it in your inbox. When a holiday falls on Monday, the newsletter will be distributed on the next business day. If you have not received your weekly e-newsletter, please contact Member Services at [email protected] for assistance.
+ Why haven't I received my Endocrine Daily Briefing e-newsletter?
-
We have replaced the Endocrine Daily Briefing with a new weekly e-newsletter that leverages artificial intelligence technology to deliver personalized content to you. To take advantage of this industry-leading technology, we switched to weekly delivery. Your Endocrine Briefing e-newsletter should arrive Mondays at 2 PM Eastern. If you haven’t received it, please contact Member Services at [email protected] for assistance.
+ How does the artificial intelligence-driven platform choose stories for me?
-
The AI platform, from a company called Rasa.io, categorizes content by keywords. As you click on stories, the platform uses that data to populate future issues with articles with similar keywords. This industry-leading technology is designed to create e-newsletters personalized to your interests. AI allows us to deliver tailored content to researchers and clinicians, highlighting the latest news on diverse topics such as neuroendocrinology, diabetes, endocrine-disrupting chemicals, and pituitary and adrenal health.
+ I haven’t received my new e-newsletter. What can I do?
